The Swiss government met with executives of Roche Holding AG and Novartis AG to discuss the pharmaceutical industry’s situation in light of US tariffs.

President Donald Trump’s announcement about tariffs on pharmaceutical goods imported to the United States is delayed. | ...

Swiss ministers have met with senior executives of pharmaceutical companies Roche and Novartis to discuss the outlook for the ...

Swiss ministers met with senior executives from Roche and Novartis to discuss the potential impact of U.S. import tariffs on pharmaceuticals. While pharmaceuticals currently avoid these tariffs, an ...

Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease symptoms, it said on Sunday, as a part of the company's growing development ...

The Swiss drugmaker discussed the option of selling drugs directly to patients with U.S. officials following Trump administration calls for the industry to cut prices.

The clean-up bill for Swiss pharma giant Roche's former Co Clare manufacturing site now totals €150.5m in what the company describes as "one of the largest remediation projects of its type in Europe".

Already USFDA-approved, under-the-skin jab can be administered in just seven minutes to the patient. This is dramatic cut ...

Roche had bid $91 a share in what it said was its best and final offer. But it would eventually relent and win by bidding $114.50 a share, almost $10 more than its rival, at the end of the day.